SummaryObjectiveTo test the hypothesis that early knee and hand osteoarthritis (OA) development is characterized by detectable changes in serum proteins relevant to inflammation, cell growth, activation, and metabolism several years before OA becomes radiographically evident.MethodsUsing microarray platforms that simultaneously test 169 proteins relevant to inflammation, cell growth, activation and metabolism, we conducted a case–control study nested within the Baltimore Longitudinal Study of Aging (BLSA). Subjects included 22 incident cases of OA and 66 age-, sex- and body mass index (BMI)-matched controls. Serum samples tested were obtained at the time of radiographic classification as either case or control, and up to 10 years earlier at...
Serum concentrations of two extracellular matrix molecules were determined over a 3 yr period in ind...
The underlying molecular mechanisms in osteoarthritis (OA) development are largely unknown. This stu...
Introduction: Biomarkers to identify osteoarthritis (OA) patients at risk for disease progression ar...
To test the hypothesis that early knee and hand OA development is characterized by detectable change...
To test the hypothesis that early knee and hand OA development is characterized by detectable change...
[Abstract] Currently there are no sufficiently sensitive biomarkers able to reflect changes in joint...
[Objective]: To find autoantibodies (AAbs) in serum that could be useful to predict incidence of rad...
OBJECTIVE: Knee osteoarthritis (OA) is a heterogeneous, complex joint pathology of unknown aetiology...
Osteoarthritis (OA) is a chronic degenerative joint disease. The pathogenesis is poorly understood. ...
OBJECTIVE: To determine the association between changes in serum levels of cartilage oligomeric matr...
Osteoarthritis (OA) is the most common joint disease and poses a large social and financial burden f...
Osteoarthritis (OA) is one of the most prevalent articular diseases. The identification of proteins ...
OBJECTIVE: To determine the association between changes in serum levels of cartilage oligomeric matr...
Osteoarthritis (OA) is a chronic disease with a long silent period. The hallmarks of osteoarthritis ...
SummaryObjectiveTo determine the association between changes in serum levels of cartilage oligomeric...
Serum concentrations of two extracellular matrix molecules were determined over a 3 yr period in ind...
The underlying molecular mechanisms in osteoarthritis (OA) development are largely unknown. This stu...
Introduction: Biomarkers to identify osteoarthritis (OA) patients at risk for disease progression ar...
To test the hypothesis that early knee and hand OA development is characterized by detectable change...
To test the hypothesis that early knee and hand OA development is characterized by detectable change...
[Abstract] Currently there are no sufficiently sensitive biomarkers able to reflect changes in joint...
[Objective]: To find autoantibodies (AAbs) in serum that could be useful to predict incidence of rad...
OBJECTIVE: Knee osteoarthritis (OA) is a heterogeneous, complex joint pathology of unknown aetiology...
Osteoarthritis (OA) is a chronic degenerative joint disease. The pathogenesis is poorly understood. ...
OBJECTIVE: To determine the association between changes in serum levels of cartilage oligomeric matr...
Osteoarthritis (OA) is the most common joint disease and poses a large social and financial burden f...
Osteoarthritis (OA) is one of the most prevalent articular diseases. The identification of proteins ...
OBJECTIVE: To determine the association between changes in serum levels of cartilage oligomeric matr...
Osteoarthritis (OA) is a chronic disease with a long silent period. The hallmarks of osteoarthritis ...
SummaryObjectiveTo determine the association between changes in serum levels of cartilage oligomeric...
Serum concentrations of two extracellular matrix molecules were determined over a 3 yr period in ind...
The underlying molecular mechanisms in osteoarthritis (OA) development are largely unknown. This stu...
Introduction: Biomarkers to identify osteoarthritis (OA) patients at risk for disease progression ar...